Jason Cardiff, previously granted bail on a $500,000 appearance bond, was declared a fugitive by a United States court in February 2025. The Department of Justice confirmed an arrest warrant for him on March 4, 2025, following his failure to return to the United States by a court-mandated deadline. This development escalates the legal proceedings against Cardiff, who faces serious fraud charges.

The court's decision to declare Cardiff a fugitive stemmed from an ex-parte motion filed by the Department of Justice on February 4, 2025. This motion specifically requested the court to designate Cardiff as a fugitive and to issue an arrest warrant. The court responded quickly, issuing an order on February 5, 2025, which confirmed his fugitive status and stated an arrest warrant would follow. This legal action marks a critical step in the federal government's attempt to compel his return.

Cardiff's legal troubles began in late 2023 when he was arrested on fraud charges. These accusations are linked to Redwood Scientific Laboratories, a company under his direction. Redwood Scientific Laboratories also operated RengaLife, a multi-level marketing (MLM) enterprise. The fraud allegations typically involve deceptive business practices or misrepresentations common in certain MLM structures, though specific details of the charges remain under seal in the initial public reports.

Following his arrest, Cardiff secured his temporary release by posting a $500,000 appearance bond. This bond served as a guarantee that he would attend all future court proceedings. Despite facing significant charges, the court granted Cardiff permission to travel to Ireland in July 2024. Such travel permissions are often contingent on strict conditions and a clear understanding of return dates.

While in Ireland, Cardiff reported experiencing "unexpected serious health problems." He asserted these medical issues necessitated an extended stay abroad, preventing his timely return to the United States. However, on December 20, 2024, the court issued a clear directive, ordering Cardiff to return to the US by January 19, 2025. The court's order included a stern warning: "absent extenuating circumstances," it was "unlikely to grant future requests to travel or extend travel."

Cardiff attempted to present his ongoing health concerns as the "extenuating circumstances" required to justify his absence. The court, however, remained unconvinced by his explanations. His failure to return by the January 19 deadline directly resulted in the court vacating his scheduled trial date of July 15, 2025. This action signals the court's view that Cardiff has deliberately avoided legal proceedings.

Before the formal declaration of fugitive status, Irish authorities made an attempt to apprehend Cardiff. On January 14, 2025, they acted on a previously granted extradition warrant. Cardiff claimed that when officers approached him, he presented documents proving his legal permission to be in Ireland. The Irish officers reportedly confiscated both his and his wife's passports, but did not proceed with an arrest at that time.

Cardiff holds Irish citizenship, a factor that complicates potential future extradition efforts. This dual nationality raises questions about the jurisdiction and the willingness of Irish authorities to re-engage in an arrest, especially given their previous encounter where they did not detain him. The presence of an active US arrest warrant, however, means Cardiff faces arrest should he leave Ireland or if Irish authorities decide to act on the extradition request.

The Department of Justice has formally confirmed the issuance of an arrest warrant for Jason Cardiff. Concurrently, the DOJ has moved to forfeit his $500,000 appearance bond, citing his clear non-compliance with judicial orders and his declared status as a fugitive from American justice. This forfeiture seeks to recover the financial guarantee made for his appearance.